Brief Internet-delivered CBT After ACS
Brief Internet-delivered Exposure-based Therapy to Reduce Post-traumatic Stress Symptoms and Cardiac Anxiety After Acute Coronary Syndrome: a Pilot Randomized Clinical Trial
1 other identifier
interventional
31
1 country
2
Brief Summary
The purpose of the present pilot study is to evaluate the feasibility and potential efficacy of a brief, internet-delivered CBT protocol provided early after acute coronary syndrome (ACS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2022
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedStudy Start
First participant enrolled
May 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 21, 2024
CompletedAugust 27, 2024
August 1, 2024
1.3 years
October 27, 2022
August 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Seattle Angina Questionnaire
A measure of coronary artery disease on five scales: physical limitation scale, anginal stability scale, anginal frequency scale, treatment satisfaction scale, and the disease perception scale. With a score ranging from 0 to 100. A higher score indicating a better quality of life.
Baseline to 3 months
Acceptability: Client satisfaction Questionnaire
Treatment satisfaction, score ranging from 0 to 32, with a higher score indication more satisfaction with the treatment.
Baseline to 5 weeks
Percentage of enrolled participants who complete the treatment
Feasibility of the intervention components will be assessed by \>60% assessed as treatment completers. Descriptive analysis will also provide number of messages and therapist time.
Baseline to 5 weeks
Adverse events
Potential adverse reactions to the treatment. Participants will be asked to report and rate the short- and long term discomfort of the adverse event on a scale from 0 ('did not affect me at all') and 3 ('affected me very negatively').
Baseline to 5 weeks
Secondary Outcomes (41)
Seattle Angina Questionnaire
Baseline to 5 weeks
Seattle Angina Questionnaire
Baseline to 7 months
Seattle Angina Questionnaire
Change over 5 measurement points measured from baseline and weekly for 5 weeks during treatment
The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5
Baseline to 5 weeks
The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5
Baseline to 3 months
- +36 more secondary outcomes
Other Outcomes (4)
Adverse events
Baseline to 3 months
Adverse events
Baseline to 7 months
Adverse events
5 measurement points measured from baseline and weekly for 5 weeks during treatment
- +1 more other outcomes
Study Arms (2)
Brief exposure-based CBT
EXPERIMENTAL* Patient education: Common reactions following ACS. The role of PTS, cardiac anxiety and avoidance behavior on quality of life and physical health and health behaviors. * Labeling i.e., describe cardiac-related symptoms, thoughts, and feelings. * Imaginal exposure to reduce PTSS: Imaginal processing and revisiting of the memory of the ACS * Interoceptive exposure to physical sensations (e.g., palpitations due to physical activity) to reduce fear of these symptoms. * Gradual exposure in-vivo to avoided situations, activities and physical activity. Continuously use labeling while conducting exposure exercises. * Relapse prevention: Prevention of relapse into avoidance behaviors by identifying risk situations and encouragement of maintaining a healthy physically active lifestyle.
Waitlist control
NO INTERVENTIONThe waitlist control will be offered an opportunity to participate in the intervention after the 2-month intervention evaluation period.
Interventions
The 5-week intervention is psychologist-guided and delivered via text-based interactive online treatment modules, where patients complete weekly homework assignments and have regular online contact with psychologists with training in CBT for cardiac disease. Key components include imaginal exposure of the ACS event, interoceptive exposure through at home physical activity that stimulats the CV system, exposure in-vivo to reduce avoided situations, and activities to enhance physical activity wellbeing. Labeling (i.e., describing cardiac-related symptoms, thoughts, and feelings) will be used continuously during treatment to enhance the effect of exposure.
Eligibility Criteria
You may qualify if:
- (A) ACS ≥ four weeks to six months before assessment (MI type 1 STEMI/NSTEMI and UA)
- (B) Age 18-80 years
- (C) Symptoms of PTSD and/or cardiac anxiety that leads to distress and/or interferes with daily life (PCL5; ≥ 10, CAQ: ≥20)
- (D) On standard of care medical treatment for the cardiac condition according to Swedish cardiovascular guidelines
- (E) Ability to read and write in Swedish.
You may not qualify if:
- (F) Heart failure with severe systolic dysfunction (ejection fraction ≤ 35%)
- (G) Significant valvular disease
- (H) Planned coronary artery bypass surgery or percutaneous interventions
- (I) Any medical restriction to physical exercise
- (J) Severe uncontrolled medical illness i.e., advanced cancer
- (K) Grade 3 hypertension (i.e., blood pressure ≥ 180 systolic and/or 110 diastolic)
- (L) Severe psychiatric disorder, active suicidal ideations or cognitive impairment that precludes provision of informed consent or study activities
- (M) Alcohol dependency
- (N) Ongoing psychological treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Columbia Universitycollaborator
Study Sites (2)
Karolinska University Hospital
Stockholm, 11635, Sweden
Karolinska Institutet
Stockholm, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PhD, Lic. psychologist
Study Record Dates
First Submitted
October 27, 2022
First Posted
November 7, 2022
Study Start
May 18, 2023
Primary Completion
August 21, 2024
Study Completion
August 21, 2024
Last Updated
August 27, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share